News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,499 Results
Type
Article (14056)
Company Profile (283)
Press Release (249160)
Section
Business (79426)
Career Advice (152)
Deals (13212)
Drug Delivery (34)
Drug Development (50379)
Employer Resources (31)
FDA (5699)
Job Trends (5120)
News (144245)
Policy (10022)
Tag
Academia (901)
Alliances (21590)
Alzheimer's disease (783)
Antibody-drug conjugate (ADC) (70)
Approvals (5686)
Artificial intelligence (90)
Bankruptcy (99)
Best Places to Work (4551)
Biotechnology (232)
Breast cancer (123)
Cancer (1044)
Cardiovascular disease (84)
Career advice (132)
CAR-T (86)
Cell therapy (248)
Clinical research (40433)
Collaboration (401)
Compensation (156)
COVID-19 (1019)
C-suite (104)
Cystic fibrosis (73)
Data (1073)
Diabetes (98)
Diagnostics (1245)
Earnings (29085)
Events (47483)
Executive appointments (328)
FDA (6148)
Funding (387)
Gene editing (72)
Gene therapy (188)
GLP-1 (336)
Government (1069)
Healthcare (6560)
Infectious disease (1062)
Inflammatory bowel disease (100)
IPO (7235)
Job creations (859)
Job search strategy (127)
Layoffs (194)
Legal (1381)
Lung cancer (156)
Manufacturing (95)
Medical device (2566)
Medtech (2567)
Mergers & acquisitions (6185)
Metabolic disorders (298)
Neuroscience (1079)
NextGen: Class of 2025 (2013)
Non-profit (852)
Northern California (1246)
Obesity (162)
Opinion (94)
Parkinson's disease (87)
Patents (72)
People (25279)
Phase I (14274)
Phase II (18805)
Phase III (11887)
Pipeline (463)
Postmarket research (852)
Preclinical (5983)
Radiopharmaceuticals (208)
Rare diseases (234)
Real estate (1411)
Regulatory (8383)
Research institute (932)
Series A (75)
Southern California (1117)
Startups (1968)
United States (9885)
Vaccines (179)
Weight loss (94)
Date
Today (65)
Last 7 days (356)
Last 30 days (1619)
Last 365 days (20444)
2025 (1671)
2024 (20553)
2023 (22415)
2022 (26823)
2021 (27805)
2020 (23357)
2019 (16225)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (147)
Asia (17044)
Australia (2884)
California (2844)
Canada (900)
China (255)
Colorado (108)
Connecticut (118)
Delaware (65)
Europe (36664)
Florida (324)
Georgia (84)
Illinois (181)
Indiana (69)
Maryland (373)
Massachusetts (2259)
Minnesota (114)
New Jersey (711)
New York (783)
North Carolina (452)
Northern California (1246)
Ohio (91)
Pennsylvania (538)
South America (207)
Southern California (1117)
Texas (318)
Washington State (273)
263,499 Results for "dianthus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences
January 30, 2025
·
1 min read
Press Releases
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
November 5, 2024
·
1 min read
Genetown
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
Dianthus Therapeutics, Inc. today announced its participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will present a corporate overview on Thursday, June 6, 2024 at 1:30 p.m. ET in New York.
May 30, 2024
·
4 min read
Genetown
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
Dianthus Therapeutics, Inc. reported financial results for the first quarter ending March 31, 2024, and provided an update on recent business achievements.
May 9, 2024
·
10 min read
Press Releases
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
November 8, 2024
·
12 min read
Genetown
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, announced its participation in the Bank of America Securities 2024 Health Care Conference.
May 8, 2024
·
4 min read
Drug Development
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
Dianthus Therapeutics, Inc. announced U.S. Food and Drug Administration clearance of its Phase 2 Investigational New Drug application for the MoMeNtum trial of DNTH103 in patients with Multifocal Motor Neuropathy.
June 12, 2024
·
6 min read
Genetown
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
Dianthus Therapeutics, Inc. announced that it granted equity awards on May 1, 2024, to two newly-hired, non-executive employees.
May 3, 2024
·
1 min read
Genetown
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)
Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced two poster presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN), taking place June 29-July 2, 2024 in Helsinki.
June 28, 2024
·
6 min read
1 of 26,350
Next
